MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $146,000 | +21.7% | 12,874 | +192.6% | 0.04% | +70.8% |
| Q4 2019 | $120,000 | +87.5% | 4,400 | +91.4% | 0.02% | +26.3% |
| Q2 2019 | $64,000 | -52.2% | 2,299 | -51.1% | 0.02% | -55.8% |
| Q4 2018 | $134,000 | -68.1% | 4,700 | -48.2% | 0.04% | -45.6% |
| Q3 2018 | $420,000 | -23.1% | 9,077 | -38.3% | 0.08% | -36.3% |
| Q2 2018 | $546,000 | +144.8% | 14,700 | +96.0% | 0.12% | +125.5% |
| Q1 2018 | $223,000 | -21.8% | 7,500 | -9.6% | 0.06% | -15.4% |
| Q4 2017 | $285,000 | +72.7% | 8,300 | +29.7% | 0.06% | +170.8% |
| Q2 2017 | $165,000 | -64.7% | 6,400 | -73.8% | 0.02% | -55.6% |
| Q1 2017 | $468,000 | -16.1% | 24,400 | -27.2% | 0.05% | -22.9% |
| Q4 2016 | $558,000 | -58.1% | 33,500 | -23.0% | 0.07% | -62.0% |
| Q2 2016 | $1,331,000 | +24.0% | 43,500 | +51.8% | 0.18% | +48.4% |
| Q1 2016 | $1,073,000 | +128.3% | 28,663 | +163.0% | 0.12% | +113.8% |
| Q4 2015 | $470,000 | +54.6% | 10,900 | +34.6% | 0.06% | +65.7% |
| Q3 2015 | $304,000 | – | 8,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |